• Genfit’s elafibranor hits goal in phase 2 PBC trial fiercebiotech
    December 29, 2018
    A phase 2 trial of Genfit’s elafibranor in primary biliary cholangitis (PBC) has hit its primary endpoint. The readout sets Genfit up to start a pivotal trial in PBC and thereby expand its late-phase pipeline beyond NASH.....
PharmaSources Customer Service